DEL VALLE-SMITH-HALVORSON. 20 ILCS 2215/4-2 from Ch. 111 1/2, par. 6504-2 Amends the Illinois Health Finance Reform Act. Provides that the Illinois Health Care Cost Containment Council shall require any pharmaceutical company that provides prescription drugs in Illinois to disclose to the Council, in a manner and fashion designated by the Council by rule, all prescription drug advertising and promotion costs. Further provides that the Council must conduct a cost/benefit analysis to determine (i) the impact of these costs on prescription drug prices and (ii) the impact on Illinois residents of any increase of the prices and costs of prescription drugs that is attributable to the advertising and promotional activities. FEB-05-2002 S FIRST READING FEB-05-2002 S ADDED AS A CHIEF CO-SPONSOR SMITH FEB-05-2002 S REFERRED TO SENATE RULES COMMITTEE RULES FEB-06-2002 S ADDED AS A CHIEF CO-SPONSOR HALVORSON JAN-07-2003 S SESSION SINE DIE END OF INQUIRY Full Text Bill Summary